Innovent Announced 2021 Annual Results

/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Related Keywords

China ,Hong Kong ,Suzhou ,Jiangsu ,Chinese ,Innovent Biologics ,Ascentage Pharma ,Adimab Incyte ,Michael Yu ,Eli Lilly ,Innovent Us Lab ,National Reimbursement Drug List ,Prnewswire Innovent Biologics Inc ,Md Anderson Cancer Center ,Harvest Year ,Product Revenue ,Late Stage Pipeline Potential ,New Drug Application ,Expedited Speed ,Non Small Cell Lung Cancer ,Infrastructure Set ,Scientific Advisory Board ,Meaningful Collaboration ,Genfleet Therapeutics ,Commercial Facility ,Main Board ,Stock Exchange ,Hong Kong Limited ,Cancer Center ,